Mesenchymal cells recruit and regulate T regulatory cells

被引:279
作者
Di Lanni, Mauro [2 ]
Del Papa, Beatrice [2 ]
De Loanni, Maria [2 ]
Moretti, Lorenzo [2 ]
Bonifacio, Elisabetta [2 ]
Cecchini, Debora [2 ]
Sportoletti, Paolo [2 ]
Falzetti, Franca [2 ]
Tabilio, Antonio [1 ]
机构
[1] Univ Aquila, Dept Internal Med & Publ Hlth, I-67100 Laquila, Italy
[2] Univ Perugia, Hematol & Clin Immunol Sect, Dept Clin & Expt Med, I-06100 Perugia, Italy
关键词
D O I
10.1016/j.exphem.2007.11.007
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. Despite much investigation into T regulatory cells (Tregs), little is known about the mechanism controlling their recruitment and function. Because multipotent mesenchymal stromal cells (MSCs) exert an immune regulatory function and suppress T-cell proliferation, this in vitro study investigated their role in Treg recruitment and function. Materials and Methods. Human MSCs and different T cell populations (CD3(+), CD3(+)/ CD45RA(+), CD3(+)/CD45RO(+), CD4(+)/CD25(+), CD4(+)/CD25(+)/CD45RO(+), CD4(+)/CD25(+)/CD45RA(+)) from healthy donors were cocultured for up to 15 days. Harvested lymphocytes were analyzed by flow cytometry and FoxP3 and CD127 expressions were measured by real-time polymerase chain reaction. Their regulatory activity was assessed. Results. We demonstrate MSC recruit Tregs from a fraction of CD3(+) and from immunoselected CD3(+)/CD45RA(+) and CD3(+)/CD45RO(+) fractions. After culture with MSCs both immunoselected fractions registered increases in the CD4(+)/CD25(bright)/FoxP3 subset and CD127 expression was downregulated. When purified Treg populations (CD4/CD25(+), CD4/CD25(+)/ CD45RA(+), and CD4/CD25(+)/CD45RO(+)) are used in MSC cocultures, they maintain FoxP3 expression and CD127 expression is downregulated. Treg suppressive capacity was maintained in Treg populations that were layered on MSC for up to 15 days while control Tregs lost all suppressive activity after 5 days culture. Conclusions. In conclusion, our study demonstrates that MSCs recruit, regulate, and maintain T-regulatory phenotype and function over time. (C) 2008 ISEH - Society for Hematology and Stem Cells. Published by Elsevier Inc.
引用
收藏
页码:309 / 318
页数:10
相关论文
共 33 条
[1]   CD4+CD25high regulatory cells in human peripheral blood [J].
Baecher-Allan, C ;
Brown, JA ;
Freeman, GJ ;
Hafler, DA .
JOURNAL OF IMMUNOLOGY, 2001, 167 (03) :1245-1253
[2]   Adhesion molecules involved in the interactions between early T cells and mesenchymal bone marrow stromal cells [J].
Barda-Saad, M ;
Rozenszajn, LA ;
Ashush, H ;
Shav-Tal, Y ;
Ben Nun, A ;
Zipori, D .
EXPERIMENTAL HEMATOLOGY, 1999, 27 (05) :834-844
[3]   Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo [J].
Bartholomew, A ;
Sturgeon, C ;
Siatskas, M ;
Ferrer, K ;
McIntosh, K ;
Patil, S ;
Hardy, W ;
Devine, S ;
Ucker, D ;
Deans, R ;
Moseley, A ;
Hoffman, R .
EXPERIMENTAL HEMATOLOGY, 2002, 30 (01) :42-48
[4]   Human mesenchymal stem cells induce T cell anergy and downregulate T cell allo-responses via the TH2 pathway: Relevance to tissue engineering human heart valves [J].
Batten, Puspa ;
Sarathchandra, Padmini ;
Antoniw, Joseph W. ;
Tay, Szun Szun ;
Lowdell, Mark W. ;
Taylor, Patricia M. ;
Yacoub, Magdi H. .
TISSUE ENGINEERING, 2006, 12 (08) :2263-2273
[5]   Distinct IL-2 receptor signaling pattern in CD4+CD25+ regulatory T cells [J].
Bensinger, SJ ;
Walsh, PT ;
Zhang, JD ;
Carroll, M ;
Parsons, R ;
Rathmell, JC ;
Thompson, CB ;
Burchill, MA ;
Farrar, MA ;
Turka, LA .
JOURNAL OF IMMUNOLOGY, 2004, 172 (09) :5287-5296
[6]   Optimization of in vitro expansion of human multipotent mesenchymal stromal cells for cell-therapy approaches: Further insights in the search for a fetal calf serum substitute [J].
Bernardo, M. E. ;
Avanzini, M. A. ;
Perotti, C. ;
Cometa, A. M. ;
Moretta, A. ;
Lenta, E. ;
Del Fante, C. ;
Novara, F. ;
De Silvestri, A. ;
Amendola, G. ;
Zuffardi, O. ;
Maccario, R. ;
Locatelli, F. .
JOURNAL OF CELLULAR PHYSIOLOGY, 2007, 211 (01) :121-130
[7]  
DEJBAKHSHJONES S, 1995, J IMMUNOL, V155, P3338
[8]   Interleukin 7-engineered stromal cells: A new approach for hastening naive T cell recruitment [J].
Di Ianni, M ;
Del Papa, B ;
De Ioanni, M ;
Terenzi, A ;
Sportoletti, P ;
Moretti, L ;
Falzetti, F ;
Gaozza, E ;
Zei, T ;
Spinozzi, F ;
Bagnis, C ;
Mannoni, P ;
Bonifacio, E ;
Falini, B ;
Martelli, MF ;
Tabilio, A .
HUMAN GENE THERAPY, 2005, 16 (06) :752-764
[9]   Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli [J].
Di Nicola, M ;
Carlo-Stella, C ;
Magni, M ;
Milanesi, M ;
Longoni, PD ;
Matteucci, P ;
Grisanti, S ;
Gianni, AM .
BLOOD, 2002, 99 (10) :3838-3843
[10]   Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement [J].
Dominici, M. ;
Le Blanc, K. ;
Mueller, I. ;
Slaper-Cortenbach, I. ;
Marini, F. C. ;
Krause, D. S. ;
Deans, R. J. ;
Keating, A. ;
Prockop, D. J. ;
Horwitz, E. M. .
CYTOTHERAPY, 2006, 8 (04) :315-317